According to multiple media reports, GlaxoSmithKline has issued a voluntary recall of its Ventolin and Seretide inhaler devices in the UK and other markets outside the United States.

The issue, which occurred during the assembly of the devices, involved a foil strip containing the medicine inside the device which may have been damaged, reducing the full number of doses the inhaler may deliver.

The issue, which affected one day of production or about 200,000 units, has been fixed, he said. The inhalers were assembled in June of last year at GSK’s site in Evreux, France.